KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Taxes (2019 - 2025)

Historic Change in Taxes for AbbVie (ABBV) over the last 7 years, with Q3 2025 value amounting to -$411.0 million.

  • AbbVie's Change in Taxes fell 90588.24% to -$411.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 billion, marking a year-over-year decrease of 22303.82%. This contributed to the annual value of -$3.2 billion for FY2024, which is 55737.7% down from last year.
  • According to the latest figures from Q3 2025, AbbVie's Change in Taxes is -$411.0 million, which was down 90588.24% from -$1.4 billion recorded in Q2 2025.
  • AbbVie's 5-year Change in Taxes high stood at $438.0 million for Q1 2022, and its period low was -$1.8 billion during Q2 2024.
  • In the last 5 years, AbbVie's Change in Taxes had a median value of $33.0 million in 2023 and averaged -$308.0 million.
  • As far as peak fluctuations go, AbbVie's Change in Taxes plummeted by 589230.77% in 2021, and later skyrocketed by 54545.45% in 2022.
  • Quarter analysis of 5 years shows AbbVie's Change in Taxes stood at -$662.0 million in 2021, then surged by 154.08% to $358.0 million in 2022, then grew by 14.8% to $411.0 million in 2023, then tumbled by 538.69% to -$1.8 billion in 2024, then surged by 77.2% to -$411.0 million in 2025.
  • Its Change in Taxes stands at -$411.0 million for Q3 2025, versus -$1.4 billion for Q2 2025 and $378.0 million for Q1 2025.